Biotech

All Articles

Daiichi pays for Merck $170M to develop lung cancer cells T-cell engager pact

.Merck &amp Co. has quickly recovered several of the prices of its Javelin Therapeutics buyout, pull...

BioMarin halts preclinical gene therapy for heart disease

.After BioMarin carried out a spring well-maintained of its pipeline in April, the company has actua...

Eisai plants molecular adhesive SEED with $1.5 B biobucks work

.Big Pharmas remain caught to the idea of molecular adhesive degraders. The current company to find ...

Life scientific research debt firm reveals along with $600M

.A new global life scientific research credit rating company, called Symbiotic Funding, has actually...

BMS ditches TIGIT, walking away from $200M bet on Agenus bispecific

.Bristol Myers Squibb is axing another significant bet from the Caforio period, ending a package for...

Nuvation halts wager prevention after thinking about period 1 information

.After looking at stage 1 data, Nuvation Bio has actually chosen to stop work with its one-time lead...

' Clinical intuition' led FDA consultants to back Zevra's rare health condition med

.Zevra Therapeutics' unusual illness medication seems to be on the path to permission this autumn af...

Pfizer takes $230M reached after axing neglected DMD genetics therapy

.Pfizer's phase 3 Duchenne muscle dystrophy (DMD) gene therapy breakdown has blown a $230 thousand g...

AC Immune views 'spots' prospective in Alzheimer's medicine data

.After greater than 20 years of deal with neurodegenerative ailments, Swiss biotech air conditioner ...

GSK drops ph. 2 HPV vaccine over absence of best-in-class prospective

.GSK has scrapped a stage 2 human papillomavirus (HPV) injection coming from its pipe after determin...